This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Events & Webinars
  • Podcasts
  • Resources
  • Learning Zone
  • Products
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer cross colorful
Bayer for ProfessionalsYour Resource Portal
closesearch
Recent Searches
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    Quick Watch
    Kerendia 2025 Year-End Highlights Video
    Kerendia®▼ (finerenone)​
    Kerendia UK Prescribing Information
    RP-KER-GB-1072, December 2024
    Kerendia®▼ (finerenone)​ and the Kidneys
    Breaking Barriers in CKD Management; short video series
    Kerendia UK Prescribing Information
    PP-KER-GB-0798, February 2024
    Kerendia®▼ (finerenone) Short Videos
    Kerendia UK Prescribing Information
    PP-KER-GB-0566, March 2024
    Oncology Events & Webinars
    View more
    ESMO 2024 Shorts Series
    NUBEQA® (darolutamide)
    NUBEQA Prescribing Information
    PP-NUB-GB-2082, January 2025
    BAUS 2024: Management of CV toxicity and bone health
    NUBEQA® (darolutamide)
    NUBEQA Prescribing Information
    PP-NUB-GB-2079, January 2025
    BAUS 2024: Urology and Oncology in Partnership
    NUBEQA® (darolutamide)
    NUBEQA Prescribing Information
    PP-NUB-GB-2080, January 2025
    BAUS 2024: Imaging and nmCRPC
    NUBEQA® (darolutamide)
    NUBEQA Prescribing Information
    PP-NUB-GB-2081, January 2025
    Women's Health Events & Webinars
    View more
    Mirena (52mg levonorgestrel)- The Next Chapter
    Dr Diana Mansour present Mirena's launch webinar.
    Mirena® Prescribing Information
    Kyleena® Prescribing Information
    PP-PF-WHC-IUS-GB-0078, October 2024
    How to manage heavy menstrual bleeding (HMB) in community...
    It's important to Discuss the symptoms, Check and diagnose, Treat it
    Qlaira® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0059, February 2024
    Supporting women with diabetes through the Perimenopause
    Hear from Dr Diana Mansour on how best to support your perimenopausal patients with diabetes
    Qlaira® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0096, March 2025
    How to develop a sustainable women’s health service
    Running an IUD/S service, managing capacity and supporting the IUT fitter
    PP-PF-WHC-IUS-GB-0058, February 2024
    Cardiology Events & Webinars
    View more
    REGISTER HERE - CV Summit
    3rd - 4th October 2025 | London
    Beyonttra Prescribing Information
    PP-BEY-GB-0009, July 2025
    Nephrology Events & Webinars
    View more
    Kerendia 2025 Year-End Highlights Video
    Kerendia®▼ (finerenone)​
    Kerendia UK Prescribing Information
    RP-KER-GB-1072, December 2024
    Kerendia®▼ (finerenone) Short Videos
    Kerendia UK Prescribing Information
    PP-KER-GB-0566, March 2024
    Chronic Kidney Disease Bitesize Videos
    Kerendia®▼ (finerenone)​
    Kerendia UK Prescribing Information
    PP-KER-GB-0565, February 2024
    Kerendia®▼ (finerenone)​ and the Kidneys
    Breaking Barriers in CKD Management; short video series
    Kerendia UK Prescribing Information
    PP-KER-GB-0798, February 2024
    Ophthalmology Events & Webinars
    Early Insights Case Study Webinar Series
    Key experts in medical retina, from both the UK and the US, discuss their patient cases
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2577, November 2024
    Effective Collaboration through Teamwork:
    How Bristol Eye Unit and BNSSG ICB developed a sustainable patient pathway for Medical Retina
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2410, August 2024
    Value-Based Prescribing:
    Enhancing NHS efficiency and sustainability in Ophthalmology Care
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2409, August 2024